Detalles de la búsqueda
1.
Pharmacological data of a successful 4-days-a-week regimen in HIV antiretroviral therapy (ANRS 162-4D trial).
Br J Clin Pharmacol
; 87(4): 1930-1939, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33010058
2.
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.
J Antimicrob Chemother
; 73(3): 738-747, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29186458
3.
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
J Antimicrob Chemother
; 73(8): 2120-2128, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29905808
4.
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).
J Antimicrob Chemother
; 73(8): 2129-2136, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29860402
5.
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
Lancet
; 384(9958): 1942-51, 2014 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25103176
6.
Once-daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS-165 DARULIGHT study.
Br J Clin Pharmacol
; 85(1): 277-280, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30421447
7.
Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study.
Contemp Clin Trials
; 131: 107267, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37302469
8.
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
Pharmacol Res Perspect
; 11(3): e01072, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269068
9.
Practices in research, surveillance and control of neglected tropical diseases by One Health approaches: A survey targeting scientists from French-speaking countries.
PLoS Negl Trop Dis
; 15(3): e0009246, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33661894
10.
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Clin Microbiol Infect
; 27(12): 1826-1837, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34048876
11.
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.
Clin Microbiol Infect
; 28(1): 1-5, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34763056
12.
Prevalence and Genetics of Leber Hereditary Optic Neuropathy in the Danish Population.
Invest Ophthalmol Vis Sci
; 57(3): 1370-5, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27007794
13.
Acceptance rate of clinical study endpoints and adequacy of source documentation: experience from clinical study endpoint review in NEAT001/ANRS143.
J Int AIDS Soc
; 17(4 Suppl 3): 19572, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25394079
Resultados
1 -
13
de 13
1
Próxima >
>>